FMOD and breast carcinoma: A short study using overexpression of FMOD in murine mammary carcinoma cell line 4T1 suggested that FMOD overexpression down regulates NF-κB and TGF-β1, implying that FMOD may inhibit cell migration which depends on the NF-κB and TGF-β1 signaling pathways (Dawoody Nejad et al., 2017).